EV/EBITDA:
-2.66+0.04(+1.48%)Summary
- As of today (September 10, 2025), DNLI EV/EBITDA is -2.66, with a rise of +0.04 (+1.48%) during the most recent trading session on September 9, 2025.
- Over the past year, DNLI EV/EBITDA has increased by +3.13 (+54.06%).
- DNLI EV/EBITDA is now -101.44% below its all-time high of 184.29.
Performance
DNLI EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
DNLI EV/EBITDA Trends
PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
---|---|---|---|
todaytoday | +1.5% | -1.4% | -0.9% |
1 m1 month | -17.2% | +17.2% | +10.0% |
3 m3 months | +0.8% | +2.6% | +4.9% |
6 m6 months | +20.1% | -15.3% | -8.0% |
ytdytd | +39.1% | -35.5% | -24.6% |
1 y1 year | +54.1% | -50.5% | -40.0% |
5 y5 years | +79.5% | -51.4% | -51.3% |
DNLI EV/EBITDA Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | -2.06 | -29.1% | -2.74 | +2.9% |
3 m | 3-month | -2.06 | -29.1% | -2.85 | +6.7% |
6 m | 6-month | -1.77 | -50.3% | -3.33 | +20.1% |
1 y | 1-year | -1.77 | -50.3% | -7.58 | +64.9% |
3 y | 3-year | -1.77 | -50.3% | -20.31 | +86.9% |
5 y | 5-year | 184.29 | -101.4% | -44.64 | +94.0% |
alltime | all time | 184.29 | -101.4% | -59.99 | +95.6% |
DNLI EV/EBITDA History
Date | Value |
---|---|
2025 | -2.66(-39.1%) |
2024 | -4.37(-60.0%) |
2023 | -10.93(+45.5%) |
2022 | -7.51(-53.2%) |
Date | Value |
---|---|
2021 | -16.04(-112.9%) |
2020 | 124.45(-2000.0%) |
2019 | -6.55(-86.2%) |
2018 | -47.48(+118.4%) |
2017 | -21.74 |
FAQ
- What is Denali Therapeutics Inc. EV/EBITDA?
- What is the all time high EV/EBITDA for Denali Therapeutics Inc.?
- What is DNLI EV/EBITDA year-to-date change?
- What is Denali Therapeutics Inc. EV/EBITDA year-on-year change?
What is Denali Therapeutics Inc. EV/EBITDA?
The current EV/EBITDA of DNLI is -2.66
What is the all time high EV/EBITDA for Denali Therapeutics Inc.?
Denali Therapeutics Inc. all-time high EV/EBITDA is 184.29
What is DNLI EV/EBITDA year-to-date change?
Denali Therapeutics Inc. EV/EBITDA has changed by +1.71 (+39.13%) since the beginning of the year
What is Denali Therapeutics Inc. EV/EBITDA year-on-year change?
Over the past year, DNLI EV/EBITDA has changed by +3.13 (+54.06%)